01 October 2020 2 Min Read
Bayer slumps on bleaker outlook and possible writedown
Shares in the pesticides and seeds maker dropped more than 12% to a six-month low, stripping more than €5bn off the company’s market value
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In